Semaglutide is a GLP-1 medicine sold as Wegovy for chronic weight management and as Ozempic for type 2 diabetes.
Richmond's health picture
Richmond is an independent city, so CDC's county-level figures describe the city itself: 37.7% of adults have obesity and 12.9% have diagnosed diabetes [1]. The city had 237,257 residents in July 2025 and a median household income of $64,587 [4]. At that income, whether insurance pays makes a large difference.
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in Richmond, from $300 a month.
A practice pays for that sponsored slot, and it carries a label. It is not a recommendation. See how we make money.
Virginia Medicaid still covers obesity drugs
Virginia is one of the few states still paying for obesity GLP-1s through Medicaid: Stateline, citing KFF, listed it among covering states in 2026 [2], and KFF counted only 13 such programs in January 2026 [5]. A Richmond Medicaid member should ask the plan for its Wegovy or Zepbound prior authorization rules before buying anything cash. Stateline also reported more states weighing cuts, so recheck the rules each year [2].
If you are paying cash
At Richmond's median income, a year of the Wegovy pen at $349 a month, $4,188 [3], equals about 6.5% of household income [4]. The Wegovy pill costs less at lower doses.
| Product and dose | Price each month | Source |
|---|---|---|
| Wegovy pill, 1.5 mg / 4 mg / 9 and 25 mg | $149 / $199 / $299 | [3] |
| Wegovy pen, intro / standard | $199 / $349 | [3] |
| Ozempic, 0.25 to 1 mg | $349 | [6] |
| Zepbound (tirzepatide) | $299 to $449 | [7] |
Tirzepatide in Richmond
For weight loss, tirzepatide is sold as Zepbound, and LillyDirect charges $299 to $449 a month depending on the dose [7]. The SURMOUNT-5 head-to-head trial found average weight loss at 72 weeks of 20.2% with tirzepatide and 13.7% with semaglutide [8]. Side by side: Wegovy vs Zepbound.
Finding care
No Richmond hospital weight program with a posted price turned up this month, so ask your doctor or health system whether it prescribes GLP-1s and what a self-pay visit costs. The Virginia Board of Medicine licenses physicians in the state [9]. Our clinic checklist and online program comparison help. Along the East Coast: Washington, DC, Baltimore, Raleigh. Start at medical weight loss.
Semaglutide label warnings
Wegovy and Ozempic carry a boxed warning based on thyroid C-cell tumors in rodents. They are contraindicated in MEN 2 and when the patient or a relative has had medullary thyroid carcinoma [10]. Get prompt care for severe belly pain that persists, an allergic reaction, or low blood sugar if you also take insulin or a sulfonylurea. Wegovy should be stopped when a pregnancy is recognized [10]. Compounded semaglutide has no FDA approval, and the agency does not assess its safety, effectiveness or quality [11]. Emergencies: call 911.
Questions people ask
Does Virginia Medicaid pay for semaglutide for weight loss?
Stateline, citing KFF, named Virginia among states whose Medicaid programs covered GLP-1s for obesity in 2026 [2]. Prior authorization criteria apply, so ask your plan.
What does Wegovy cost in Richmond without insurance?
On Oct 17, 2026 the pill was $149 at 1.5 mg, $199 at 4 mg and $299 at 9 or 25 mg, and the pen was $349 a month, or $199 for two intro fills [3].
Why are Richmond's obesity numbers county-level data?
Richmond is an independent city, so CDC's county figures describe the city itself: 37.7% of adults with obesity and 12.9% with diagnosed diabetes [1].
How much of a Richmond household budget would Wegovy take?
What does Zepbound cost a Richmond cash buyer?
LillyDirect listed $299 to $449 a month by dose on Oct 17, 2026 [7].
Where do Richmond patients check a doctor's license?
The Virginia Board of Medicine keeps the state's physician license records [9].
Sources
11 cited
- PLACES county data, 2025 release: Richmond city, VA. Centers for Disease Control and Prevention, 2025 release (2023 BRFSS).
- More states consider dropping GLP-1 weight loss drugs from Medicaid. Stateline (States Newsroom), Apr 30, 2026.
- Wegovy self-pay offer, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- QuickFacts: Richmond city, Virginia. U.S. Census Bureau, 2025 estimates and 2020-2024 ACS; accessed 2026-10-17.
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
- Ozempic self-pay, NovoCare Pharmacy. Novo Nordisk (NovoCare), Oct 17, 2026.
- Zepbound self-pay prices on LillyDirect. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
- Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). New England Journal of Medicine (PubMed), 2025.
- Virginia Board of Medicine. Virginia Department of Health Professions, Oct 17, 2026.
- Wegovy label (injection and tablets). DailyMed, National Library of Medicine, Jun 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.